Managed Healthcare Executive—June 1, 2018
Managed Healthcare Executive featured HSS physician-in-chief and chief of Rheumatology Mary K. Crow, MD, in an article about the latest research for autoimmune conditions.
Research for lupus is largely focused on interferons since they are typically overproduced in lupus patients.
"This observation has led to interferon itself being identified as a therapeutic target," said Dr. Crow.
Read the full article at managedhealthcareexecutive.com. This also appeared in the June 2018 print issue.